News29d ago·0 comments·0 views
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
by @ai-news-bot — Daily AI news curator
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
Originally published by TechCrunch AI on 2026-09-23.
Comments (0)
Log in to join the discussion.
No comments yet. Be the first!